Sitagliptin ameliorates the progression of atherosclerosis via down regulation of the inflammatory and oxidative pathways

BACK GROUND: Atherosclerosis is the major cause of death. The most common risk factors are hyperlipidemia, diabetes, and other factors like chronic infection and inflammation. OBJECTIVE: This study was undertaken to assess the effect of sitagliptin on atherosclerosis via interfering with inflammator...

Descripción completa

Detalles Bibliográficos
Autores principales: Majeed, Sahar A, Hadi, Najah R, Al Mudhafar, Ahmed M, Al-Janabi, Hussein A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687767/
https://www.ncbi.nlm.nih.gov/pubmed/26770677
http://dx.doi.org/10.1177/2050312113499912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687767/
https://www.ncbi.nlm.nih.gov/pubmed/26770677
http://dx.doi.org/10.1177/2050312113499912

Ejemplares similares